headache
FDA Approves Qulipta for Chronic Migraine
The FDA expanded the indication for Qulipta for the preventive treatment of migraine in adults.
APRIL 18, 2023
Pediatric Infusion Center Reduces Headache Pain, Payor Cost
A study has demonstrated the success of an infusion treatment to relieve acute headache and migraine in children.
SEPTEMBER 28, 2021
Metoclopramide Plus Diphenhydramine Effective in Headache Following Trauma
In cases of post-traumatic headache, metoclopramide plus diphenhydramine provided superior relief to placebo, ...
JULY 8, 2021
IBD Patients Report Their Reactions To Biological Therapies
When IBD patients self-report their adverse reactions to biological therapies, they could provide insights that ...
MAY 6, 2021
FDA Approves First Treatment for Episodic Cluster Headache
People with episodic cluster headache represent 85% to 90% of cluster headache prevalence, with approximately ...
JUNE 5, 2019
FDA Approves Emgality for Migraine Prevention
The FDA approved galcanezumab-gnlm (Emgality, Eli Lilly) to prevent migraine in adults.
SEPTEMBER 28, 2018
FDA Determining Risk for Burns, Scars From Migraine Patch
The Zecuity patch is a single-use, battery-powered patch that is wrapped around the upper arm or thigh. Adverse ...
JUNE 6, 2016